Late-breaking abstract: The bromodomain-containing protein 4: The epigenetic origin of the oncogenic signature in pulmonary hypertension
Conclusion: Our study suggests an important role for BRD4 in pulmonary hypertension and opens the door to new avenues of investigation and proposes BRD4 as putative treatment for PAH.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Vaillancourt, M., Meloche, J., Ferraro, P., Provencher, S., Bonnet, S. Tags: 4.3 Pulmonary Circulation and Pulmonary Vascular Disease Source Type: research
More News: Cancer | Cancer & Oncology | Hypertension | Mitochondrial Disease | Pulmonary Hypertension | Respiratory Medicine | Study